Repurgenesis signed a memorandum of understanding with Switzerland’s Medvisis on July 29, 2026. The agreement establishes a framework for future collaboration using Repurgenesis’ Intelligent Orchestrator platform to advance promising drug candidates and strengthen connections with the global biotechnology and pharmaceutical industry.


Full Article — https://news.cnyes.com/news/id/6552920